Hyperhomocysteinemia as a cause of premature stroke in a young patient

Archives of Physical Medicine and Rehabilitation

Volumn 79, Issue 3, 1998, Pages 343-345

  Ray, Joel G ^a,b   Harvey, David T ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CASE REPORT; COMMON CAROTID ARTERY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; OCCLUSIVE CEREBROVASCULAR DISEASE; STROKE;

EID: 0031968829     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(98)90018-1     Document Type: Article

References (27)

1. Hart RG, Miller VT. Cerebral infarction in young adults: a practical approach. Curr Concep Cerebrovasc Dis-Stroke 1982;17: 212-7.
2. Bogousslavsky J, Regli F. Ischemic strokes in adults younger than 30 years of age. Cause and prognosis. Arch Neurol 1987;44: 479-82.
3. Bogousslavsky J, Pierre P. Ischemic stroke in patients under age 45. Neurol Clin 1992;10:113-24.
4. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet 1996;348:498-505.
5. Khaw KT, Barrett-Connor E. Family history of stroke as an independent predictor of ischemic heart disease in men and stroke in women. Am J Epidemiol 1986;123:59-66.
6. Mudd HS, Finklestein JD, Irreverre F, Laster L. Homocystinuria: an enzymatic defect. Science 1964;143:1443-5.
7. Finklestein JD, Mudd HS, Laster LK. Homocystinuria due to cystathione synthetase deficiency: the mode of inheritance. Science 1964;146:785-87.
8. Brattstrom LE, Harbebo JE, Hultberg BL. Moderate homocysteinemia. Stroke 1984;15:1012-6.
9. Araki A, Sako Y, Fukushima Y, Matsumoto M, Asada T, Kita T. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis 1989;79: 139-46.
10. Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, de Garmo P. Elevated plasma homocyst(e)ine concentration as an independent risk factor for stroke. Stroke 1990;21:572-6.
11. Brattstrom L, Lindgren A, Israelsson B, Malinow MR, Norrving B, Upson B, et al. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest 1992;22:214-21.
12. Clarke R, Fitzgerald D, O'Brien C, O'Farrell C. Hyperhomocysteinaemia: a risk factor for extracranial carotid artery atherosclerosis. Irish J Med Sci 1992;161:61-5.
13. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery intimalmedial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. Circulation 1993;87:1107-13.
14. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willet WC, Stampfer MJ. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 1994;25:1924-30.
15. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-91.
16. Lindgren A, Brattstrom L, Norrving B, Hultberg B, Andersson A, Johansson BB. Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 1995;26:795-800.
17. Perry IJ, Refsum H, Morris RW, Ebrahim SB. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-8.
18. Aronson DC, Onkenhout W, Raben AM, Oudenhoven LF, Brommer EJ, van Bockel JH. Impaired homocysteine metabolism: a risk factor in young adults with atherosclerotic arterial occlusive disease of the leg. Br J Surg 1994;81:1114-8.
19. Boushey J, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
20. Kang SS, Passen EL, Ruggie N, Wong PW, Sora H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1993;88:1463-9.
21. Erbe RW. Genetic aspects of folate metabolism. Adv Hum Genet 1979;9:293-354.
22. Kang SS, Wong PWK, Zhou J, Sora J, Lessick M, Ruggie N, et al. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism 1988;37:611-3.
23. Goyette P, Sumner JS, Milos R, Duncan AMV, Rosenthal DS, Matthews RG, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 1994;7:195-200.
24. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molby AM, et al. A genetic defect in 5, 10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995;88:763-6.
25. Franken DG, Boers GHJ, Blom HJ, Tijbels FJM, Kloppenborg PW. Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb 1994;14:465-70.
26. Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994;124:1927-33.
27. Motulsky AG. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 1996;58:17-20.